“Therapeutic Use of Tolvaptan in Cancer-Related Hyponatremia: Benefits, Risks, and Clinical Guidance”. International Journal of Emerging Research in Applied Medical Sciences, vol. 2, no. 4, Apr. 2026, pp. 10-18, https://doi.org/10.65477/j29hcv64.